205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-294.74%
Both yoy net incomes decline, with ADI at -0.45%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
238.20%
Well above ADI's 100.00%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-7.27%
Negative yoy CFO while ADI is 300.00%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-36.61%
Both yoy lines negative, with ADI at -2.41%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-33.33%
Both yoy lines negative, with ADI at -725.85%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
118.75%
Proceeds from sales/maturities above 1.5x ADI's 28.57%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
50.00%
Less 'other investing' outflow yoy vs. ADI's 500.00%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-34.12%
Both yoy lines negative, with ADI at -2107.50%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
466.67%
Stock issuance far above ADI's 365.00%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.